Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
This list of potential positions covers Large Israel companies traded on major USA exchanges. Cross-sector collection of best publicly traded Israel entities that are expected to continue growing in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using Portfolio Positions Ratings and Equity Ratings tools to further calibrate your research.
Story appears to be empty
Check Point Software (CHKP)
The company has return on total asset (ROA) of 0.0984 % which means that it generated a profit of $0.0984 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2923 %, meaning that it created $0.2923 on every $100 dollars invested by stockholders. Check Point's management efficiency ratios could be used to measure how well Check Point manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Check Point's Return On Capital Employed is relatively stable compared to the past year. As of 04/23/2024, Return On Assets is likely to grow to 0.19, while Return On Tangible Assets are likely to drop 0.21. At this time, Check Point's Total Current Liabilities is relatively stable compared to the past year. As of 04/23/2024, Non Current Liabilities Total is likely to grow to about 1 B, while Liabilities And Stockholders Equity is likely to drop slightly above 3.6 B. This firm currently falls under 'Large-Cap' category with a current market capitalization of 17.83 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Check Point's market, we take the total number of its shares issued and multiply it by Check Point's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be overvalued. Check Point Software shows a prevailing Real Value of $149.59 per share. The current price of the firm is $157.95. Our model approximates the value of Check Point Software from analyzing the firm fundamentals such as return on equity of 0.29, and Profit Margin of 0.35 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor buying undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
DSP Group (DSPG)
The company has return on total asset (ROA) of (0.74) % which means that it has lost $0.74 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.99) %, meaning that it created substantial loss on money invested by shareholders. DSP's management efficiency ratios could be used to measure how well DSP manages its routine affairs as well as how well it operates its assets and liabilities. This firm currently falls under 'Small-Cap' category with a current market capitalization of 532.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DSP's market, we take the total number of its shares issued and multiply it by DSP's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Nice Ltd ADR (NICE)
The company has return on total asset (ROA) of 0.054 % which means that it generated a profit of $0.054 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1056 %, meaning that it created $0.1056 on every $100 dollars invested by stockholders. Nice's management efficiency ratios could be used to measure how well Nice manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.12. The current year's Return On Capital Employed is expected to grow to 0.12. At present, Nice's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 334.3 M, whereas Intangible Assets are forecasted to decline to about 228.5 M. This firm currently falls under 'Large-Cap' category with a current market capitalization of 14.14 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nice's market, we take the total number of its shares issued and multiply it by Nice's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Nice Ltd ADR secures a last-minute Real Value of $238.91 per share. The latest price of the firm is $224.19. Our model forecasts the value of Nice Ltd ADR from analyzing the firm fundamentals such as Profit Margin of 0.14 %, current valuation of 13.53 B, and Return On Equity of 0.11 as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend purchasing undervalued stocks and exiting overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Radware (RDWR)
The company has return on total asset (ROA) of (0.0337) % which means that it has lost $0.0337 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0624) %, meaning that it created substantial loss on money invested by shareholders. Radware's management efficiency ratios could be used to measure how well Radware manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/23/2024, Return On Tangible Assets is likely to grow to -0.04. In addition to that, Return On Capital Employed is likely to grow to -0.07. At this time, Radware's Other Assets are relatively stable compared to the past year. As of 04/23/2024, Net Tangible Assets is likely to grow to about 328 M, while Non Current Assets Total are likely to drop slightly above 163.7 M. This firm currently falls under 'Small-Cap' category with a current market capitalization of 678.62 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Radware's market, we take the total number of its shares issued and multiply it by Radware's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Net Debt
(52.33 Million)
Radware reported last year Net Debt of (49.83 Million)
Taro Pharmaceutical Industries (TARO)
The company has return on total asset (ROA) of 0.0103 % which means that it generated a profit of $0.0103 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0261 %, meaning that it created $0.0261 on every $100 dollars invested by stockholders. Taro Pharmaceutical's management efficiency ratios could be used to measure how well Taro Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of April 2024, Return On Tangible Assets is likely to grow to 0.28. Also, Return On Capital Employed is likely to grow to 0.41. At this time, Taro Pharmaceutical's Net Tangible Assets are very stable compared to the past year. As of the 23rd of April 2024, Return On Tangible Assets is likely to grow to 0.28, though Other Current Assets are likely to grow to (1.1 K). The entity currently falls under 'Mid-Cap' category with a current market capitalization of 1.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Taro Pharmaceutical's market, we take the total number of its shares issued and multiply it by Taro Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the company appears to be overvalued. Taro Pharmaceutical has a current Real Value of $38.6 per share. The regular price of the company is $42.25. Our model measures the value of Taro Pharmaceutical from inspecting the company fundamentals such as Operating Margin of 0.11 %, return on equity of 0.0261, and Shares Outstanding of 37.58 M as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Macroaxis financial leverage refers to using borrowed capital as a funding source to finance Macroaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Macroaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Macroaxis' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Macroaxis' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Macroaxis's total debt and its cash.
Macroaxis Gross Profit
Macroaxis Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Macroaxis previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Macroaxis Gross Profit growth over the last 10 years. Please check Macroaxis' gross profit and other fundamental indicators for more details.
Story appears to be empty
Check Point Software (CHKP)
The company has return on total asset (ROA) of 0.0984 % which means that it generated a profit of $0.0984 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2923 %, meaning that it created $0.2923 on every $100 dollars invested by stockholders. Check Point's management efficiency ratios could be used to measure how well Check Point manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Check Point's Return On Capital Employed is relatively stable compared to the past year. As of 04/23/2024, Return On Assets is likely to grow to 0.19, while Return On Tangible Assets are likely to drop 0.21. At this time, Check Point's Total Current Liabilities is relatively stable compared to the past year. As of 04/23/2024, Non Current Liabilities Total is likely to grow to about 1 B, while Liabilities And Stockholders Equity is likely to drop slightly above 3.6 B. This firm currently falls under 'Large-Cap' category with a current market capitalization of 17.83 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Check Point's market, we take the total number of its shares issued and multiply it by Check Point's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be overvalued. Check Point Software shows a prevailing Real Value of $149.59 per share. The current price of the firm is $157.95. Our model approximates the value of Check Point Software from analyzing the firm fundamentals such as return on equity of 0.29, and Profit Margin of 0.35 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor buying undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
DSP Group (DSPG)
The company has return on total asset (ROA) of (0.74) % which means that it has lost $0.74 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.99) %, meaning that it created substantial loss on money invested by shareholders. DSP's management efficiency ratios could be used to measure how well DSP manages its routine affairs as well as how well it operates its assets and liabilities. This firm currently falls under 'Small-Cap' category with a current market capitalization of 532.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DSP's market, we take the total number of its shares issued and multiply it by DSP's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Nice Ltd ADR (NICE)
The company has return on total asset (ROA) of 0.054 % which means that it generated a profit of $0.054 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1056 %, meaning that it created $0.1056 on every $100 dollars invested by stockholders. Nice's management efficiency ratios could be used to measure how well Nice manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.12. The current year's Return On Capital Employed is expected to grow to 0.12. At present, Nice's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 334.3 M, whereas Intangible Assets are forecasted to decline to about 228.5 M. This firm currently falls under 'Large-Cap' category with a current market capitalization of 14.14 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nice's market, we take the total number of its shares issued and multiply it by Nice's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Nice Ltd ADR secures a last-minute Real Value of $238.91 per share. The latest price of the firm is $224.19. Our model forecasts the value of Nice Ltd ADR from analyzing the firm fundamentals such as Profit Margin of 0.14 %, current valuation of 13.53 B, and Return On Equity of 0.11 as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend purchasing undervalued stocks and exiting overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Radware (RDWR)
The company has return on total asset (ROA) of (0.0337) % which means that it has lost $0.0337 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0624) %, meaning that it created substantial loss on money invested by shareholders. Radware's management efficiency ratios could be used to measure how well Radware manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/23/2024, Return On Tangible Assets is likely to grow to -0.04. In addition to that, Return On Capital Employed is likely to grow to -0.07. At this time, Radware's Other Assets are relatively stable compared to the past year. As of 04/23/2024, Net Tangible Assets is likely to grow to about 328 M, while Non Current Assets Total are likely to drop slightly above 163.7 M. This firm currently falls under 'Small-Cap' category with a current market capitalization of 678.62 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Radware's market, we take the total number of its shares issued and multiply it by Radware's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Net Debt
(52.33 Million)
Radware reported last year Net Debt of (49.83 Million)
Taro Pharmaceutical Industries (TARO)
The company has return on total asset (ROA) of 0.0103 % which means that it generated a profit of $0.0103 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0261 %, meaning that it created $0.0261 on every $100 dollars invested by stockholders. Taro Pharmaceutical's management efficiency ratios could be used to measure how well Taro Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of April 2024, Return On Tangible Assets is likely to grow to 0.28. Also, Return On Capital Employed is likely to grow to 0.41. At this time, Taro Pharmaceutical's Net Tangible Assets are very stable compared to the past year. As of the 23rd of April 2024, Return On Tangible Assets is likely to grow to 0.28, though Other Current Assets are likely to grow to (1.1 K). The entity currently falls under 'Mid-Cap' category with a current market capitalization of 1.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Taro Pharmaceutical's market, we take the total number of its shares issued and multiply it by Taro Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the company appears to be overvalued. Taro Pharmaceutical has a current Real Value of $38.6 per share. The regular price of the company is $42.25. Our model measures the value of Taro Pharmaceutical from inspecting the company fundamentals such as Operating Margin of 0.11 %, return on equity of 0.0261, and Shares Outstanding of 37.58 M as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management. View Profile
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Please refer to our Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com
Did you try this?
Run ETFs Now
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any private could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Stocks Directory module to find actively traded stocks across global markets.
